Living with depression that has not responded to multiple medications is an exhausting and often isolating experience. If this description aligns with where you are right now, you are not alone, and there are options beyond the antidepressants that have already fallen short. SPRAVATO® (esketamine) nasal spray is an FDA-approved treatment available at The Holiner Psychiatric Group, and it operates through a completely different mechanism than most oral medications that patients may have already tried. There are many benefits of SPRAVATO® for treating depression in Dallas because of the fact that it was specifically designed for this situation.
SPRAVATO® works by acting on the NMDA glutamate receptor system, a pathway that traditional antidepressants do not target. Rather than waiting weeks for serotonin levels to shift, many depressed Dallas patients begin noticing meaningful changes in mood within the first days of SPRAVATO® treatment.
For patients who have spent months or years trying to find relief, that difference in response time matters.
The standard antidepressant pathway works well for many people, but it does not work for everyone. When two or more adequate trials of oral antidepressants have not produced meaningful relief for Dallas patients, the diagnosis of treatment-resistant depression applies, and SPRAVATO® becomes appropriate. It is not a medication you pick up at a pharmacy and take at home. Each dose is self-administered as a nasal spray right here in our office, under direct clinical supervision. You remain with our team for a monitoring period following each esketamine session before you are cleared to leave.
The initial phase of SPRAVATO® treatment involves twice-weekly sessions, typically spanning the first four weeks. After that, the frequency is reduced based on how your symptoms are responding and what your provider recommends. Our Dallas team conducts a full evaluation before treatment begins to confirm that SPRAVATO® therapy is clinically appropriate and beneficial for you and discuss what the process will involve. Insurance coverage is available for many qualifying patients, and our staff will help you work through that process so cost does not become a barrier to care.
SPRAVATO® also has FDA approval for adults with major depressive disorder experiencing active suicidal ideation with intent or behavior. We handle these evaluations with the same thoroughness and care that guides every treatment decision we make.
You should not have to keep cycling through treatments that are not working. If treatment-resistant depression has defined your experience for longer than it should have, SPRAVATO® may represent a genuine turning point. The Holiner Psychiatric Group is ready to help you understand whether this is the right path and what the benefits of SPRAVATO® for treating depression in Dallas could mean for your life. Contact us today.